• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Monthly Archive: September 2005

  • A middle cerebral artery anueurism: International Subarachnoid Aneurism Trial (ISAT)
    • in General Medicine
    • — 27 Sep, 2005

    A middle cerebral artery anueurism: International Subarachnoid Aneurism Trial (ISAT)

    Andy Molyneux
    Andrew J Molyneux, Neurovascular Research Unit, Radcliffe Infirmary, Oxford
    REFERENCE: Lancet 2005;366:809-17
    A trans-catheter treatment for ruptured intracranial aneurysm has proved superior to traditional neurosurgical clipping in three quarters of patients presenting with subarachnoid haemorrhage. Andrew Molyneux of Oxford University
    …
    Read more
    RITA-3 Study Five Year Results: Aggressive Management of Acute Coronary Syndrome Now looks Even Better
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    RITA-3 Study Five Year Results: Aggressive Management of Acute Coronary Syndrome Now looks Even Better

    Keith Fox
    Keith Fox

    Keith Fox, Royal Infirmary Edinburgh
    The RITA-3 trial – focussing on how to manage patients with acute coronary syndromes – reported 5-year data at this year’s ESC Congress. Keith Fox from Edinburgh told Audio Medica about new evidence …

    Read more
  • Drug-Coated Balloon for In-Stent Restenosis: First Experience
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Drug-Coated Balloon for In-Stent Restenosis: First Experience

    Bruno Scheller
    Bruno Scheller

    Bruno Scheller, Universitatsklinikum des Saarlandes, Homburg Saar
    A future option for treating in-stent restenosis is the idea of coating a balloon with an anti-proliferative drug and inflating it inside the newly-occluded stent. At the ESC Congress, Bruno Scheller…

    Read more
    Endeavor: Alternative Drug-Eluting Stent?
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Endeavor: Alternative Drug-Eluting Stent?

    Jean Fajadet
    Jean Fajadet

    The ESC heard the latest on the Endeavor stent, which elutes the sirolimus analogue ABT-578. Jean Fajadet from Toulouse told Audio Medica about the findings from ENDEAVOR II study of around 1200 patients.
    [audio:https://www.audiomedica.com/podcasting/17.Jean_Fajadet-Endeavour-2_study.mp3]

    Click here for all …

    Read more
  • Europe Leaps to Action on Heart-Unfriendly Lifestyles
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Europe Leaps to Action on Heart-Unfriendly Lifestyles

    David Wood
    David Wood

    Heart disease patients need to change lifestyle and not just take medicines. That’s the message in Stockholm from the EuroAction Project, which is investigating the potential of a nurse-led patient-education initiative. David Wood from London’s Charing Cross Hospital …

    Read more
    Raw Deal for European Women with Coronary Artery Disease
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Raw Deal for European Women with Coronary Artery Disease

    Caroline Daly
    Caroline Daly

    The Euroheart survey has found significant differences in both diagnosis and treatment of heart disease in women as compared with men. Audio Medica asked Caroline Daly of London’s Royal Brompton Hospital about the clinical implications.
    [audio:https://www.audiomedica.com/podcasting/05.Caroline_Daly-The_Euroheart_survey_has_found_significant_differences.mp3]

    Click here …

    Read more
  • PREAMI: Perindopril Improves Remodelling in Older Patients with Acute Myocardial Infarction
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    PREAMI: Perindopril Improves Remodelling in Older Patients with Acute Myocardial Infarction

    Audio Medica talked with Roberto Ferrari , Vice President of the ESC, about the PREAMI study on the use of the ACE inhibitor perindopril in older patients who have survived acute myocardial infarction.
    [audio:https://www.audiomedica.com/podcasting/01.Roberto_Ferrari-about_the_PREAMI_study.mp3] Click here for all the interviews …

    Read more
    Thrombolysis Before Primary PCI Increases Mortality
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Thrombolysis Before Primary PCI Increases Mortality

    Frans Van de Werf
    Frans Van de Werf

    In the treatment of acute myocardial infarction the 24-country ASSENT-4 study seems to show an overall increase of risk if you use thrombolysis before primary PCI. Frans Van de Werf from Leuven gave Audio Medica results …

    Read more
  • Cardiac Re-Synchronisation Cuts Sudden Death
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Cardiac Re-Synchronisation Cuts Sudden Death

    John Cleland
    John Cleland

    Cardiac resynchronisation has proved even more beneficial in severe heart failure than was proven a year ago by early results from the CARE-HF study. At the European Cardiology meeting in Stockholm John Cleland of Hull has now presented …

    Read more
    CIBIS-3 Study: ACE Inhibitor before Beta Blocker for Congestive Heart Failure?
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    CIBIS-3 Study: ACE Inhibitor before Beta Blocker for Congestive Heart Failure?

    Ronnie Willenheimer
    Ronnie Willenheimer

    It could be just as good to start treatment for heart failure with a beta blocker first and subsequently use an ACE inhibitor, as the more convetional use of an ACE inhibitor first followed by a beta blocker. …

    Read more
  • Enoxaparin Shows Safety in Angioplasty – STEEPLE Study
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

    Gilles Montalescot
    Gilles Montalescot

    The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
    [audio:https://www.audiomedica.com/podcasting/15.Gilles_Montalescot-The_STEEPLE_trial_randomised_more_than_3500_elective_angioplasty_patients.mp3]

    Click here …

    Read more
    Drug-eluting Stents: Cost-Benefit Targeting?
    • in Cardiovascular · ESC 2005
    • — 12 Sep, 2005

    Drug-eluting Stents: Cost-Benefit Targeting?

    Matthias Pfisterer
    Matthias Pfisterer

    Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pfisterer from Basel. Audio Medica talked with him.
    [audio:https://www.audiomedica.com/podcasting/14.Matt_Pfisterer-Drug-eluting_stents_may_confer_so_little_additional_benefit_to_low_risk_patients.mp3]

    Click here for all the interviews …

    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • 2005
  • September

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.